Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 3/20 | 1.00 |
| ▸ | ASAH1 | Q13510 | 1/20 | 0.75 |
| ▸ | DEGS1 | O15121 | 2/20 | 0.74 |
| ▸ | PLA2G4A | P47712 | 2/20 | 0.64 |
| ▸ | CETP | P11597 | 4/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | FAAH | O00519 | 2/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.49 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6658827 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL3190081 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL6662705 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL21660329 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL22910990 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL21581283 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL22911004 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL21581286 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL21428456 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A | |
| SCHEMBL6242240 | 1.00 | MEN1 (1.00) | MEN1KMT2AASAH1DEGS1PLA2G4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020006420-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | PHILIPPE MICHEL (FR) | 2002-01-17 | — | — | US | claimed |
| US-6184252-B1 | 2-amino-1,3-alkanediol compositions for inducing/stimulating hair growth and/or retarding hair loss | SOCIETE L'OREAL S.A. (FR) | 2001-02-06 | — | — | US | claimed |
| EP-1001739-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | L'OREAL (FR) | 2000-05-24 | — | — | EP | claimed |
| WO-1999007337-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | L'OREAL (FR) | 1999-02-18 | — | — | WO | claimed |
| EP-0790053-B1 | Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth | OREAL (FR) | 1998-10-07 | — | — | EP | claimed |
| EP-0790053-A1 | Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth | L'OREAL (FR) | 1997-08-20 | — | — | EP | claimed |
| EP-0722717-B1 | Use of ceramids as thickening agents | OREAL (FR) | 1997-03-19 | — | — | EP | claimed |
| EP-0722717-A1 | Use of ceramids as thickening agents | L'OREAL (FR) | 1996-07-24 | — | — | EP | claimed |
| JP-9227343-A | — | — | None | — | — | JP | disclosed |
| US-20050271692-A1 | Topical cosmetic compositions | COSMECEUTIC SOLUTIONS PTY. LTD. | 2005-12-08 | — | — | US | disclosed |
| EP-1534214-A1 | TOPICAL COSMETIC COMPOSITIONS | Cosmeceutic Solutions Pty Ltd (AU) | 2005-06-01 | — | — | EP | disclosed |
| WO-2004000242-A1 | TOPICAL COSMETIC COMPOSITIONS | COSMECEUTIC SOLUTIONS PTY LTD (AU) | 2003-12-31 | — | — | WO | disclosed |
| EP-1354870-A1 | DIHYDROCERAMIDE DESATURASE INHIBITORS. | CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (ES) | 2003-10-22 | — | — | EP | disclosed |
| US-20020006420-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | PHILIPPE MICHEL (FR) | 2002-01-17 | — | — | US | disclosed |
| EP-0790053-B1 | Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth | OREAL (FR) | 1998-10-07 | — | — | EP | disclosed |
| US-5665699-A | Use of ceramides as thickeners | L'OREAL (FR) | 1997-09-09 | — | — | US | disclosed |
| JP-H09227343-A | DEHAIRING RETARDING AND/OR HAIR GROWTH INDUCING AND STIMULATING AGENT CONTAINING 2-AMINO-1,3-ALKANE DIOL | L'OREAL SA | 1997-09-02 | — | — | JP | disclosed |
| EP-0790053-A1 | Use of 2-amino-alkane-1,3-diol to reduce hairloss and/or to induce and stimulate hairgrowth | L'OREAL (FR) | 1997-08-20 | — | — | EP | disclosed |
| EP-0722717-B1 | Use of ceramids as thickening agents | OREAL (FR) | 1997-03-19 | — | — | EP | disclosed |
| EP-0722717-A1 | Use of ceramids as thickening agents | L'OREAL (FR) | 1996-07-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050271692-A1 | Topical cosmetic compositions | CUTA, MITF, DSG1 | MEN1 2207/4885KMT2A 3646/4885ASAH1 16/4885 |
| US-20020006420-A1 | USE OF A 2-AMINO-ALKANE POLYOL AS AGENT FOR TREATING SKIN AGEING SIGNS | CUTA, GLA, AGER | MEN1 4742/4885KMT2A 527/4885ASAH1 274/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.